{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:30:43Z","timestamp":1793021443418,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","award":["CMRPG8F0211"],"award-info":[{"award-number":["CMRPG8F0211"]}],"id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.10.095","type":"journal-article","created":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T00:02:51Z","timestamp":1541289771000},"page":"658-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat"],"prefix":"10.1016","volume":"109","author":[{"given":"Chih-Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Glenn","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Chung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheung-Fat","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon-Kan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.10.095_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0141076815616091","article-title":"Cardiorenal syndrome: review of our current understanding","volume":"109","author":"Hadjiphilippou","year":"2016","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.biopha.2018.10.095_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000167018","article-title":"The cardiorenal syndrome","volume":"27","author":"Ronco","year":"2009","journal-title":"Blood Purif."},{"key":"10.1016\/j.biopha.2018.10.095_bib0015","doi-asserted-by":"crossref","first-page":"e2602","DOI":"10.1097\/MD.0000000000002602","article-title":"Low response of renin-angiotensin system to sodium intake intervention in chinese hypertensive patients","volume":"95","author":"Feng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.biopha.2018.10.095_bib0020","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1","volume":"60","author":"Ronco","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2018.10.095_bib0025","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1159\/000493657","article-title":"Kidney response to heart failure: proteomic analysis of cardiorenal syndrome","volume":"43","author":"Melenovsky","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.biopha.2018.10.095_bib0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/hr.2010.238","article-title":"Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension","volume":"34","author":"Morishita","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.biopha.2018.10.095_bib0035","doi-asserted-by":"crossref","first-page":"13902","DOI":"10.1038\/s41598-018-32308-2","article-title":"Oxidative DNA damage induced by ROS-modulating agents with the ability to target DNA: a comparison of the biological characteristics of citrus pectin and apple pectin","volume":"8","author":"Salehi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.10.095_bib0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.116.07389","article-title":"Potassium Supplementation Prevents Sodium Chloride Cotransporter Stimulation During Angiotensin II Hypertension","volume":"68","author":"Veiras","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2018.10.095_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/321714","article-title":"Antioxidants in kidney diseases: the impact of bardoxolone methyl","volume":"2012","author":"Rojas-Rivera","year":"2012","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.biopha.2018.10.095_bib0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","article-title":"NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy","volume":"35","author":"Nakagami","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2018.10.095_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000492602","article-title":"Levels of proinflammatory cytokines, oxidative stress, and tissue damage markers in patients with acute heart failure with and without cardiorenal syndrome type 1","volume":"8","author":"Virzi","year":"2018","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.biopha.2018.10.095_bib0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5494\/wjh.v2.i4.34","article-title":"Oxidative stress-mediated effects of angiotensin II in the cardiovascular system","volume":"2","author":"Wen","year":"2012","journal-title":"World J. Hypertens."},{"key":"10.1016\/j.biopha.2018.10.095_bib0065","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/152308603770380098","article-title":"Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases","volume":"5","author":"Takano","year":"2003","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2018.10.095_bib0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.metabol.2012.12.012","article-title":"Renin Inhibition and AT 1 R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling","volume":"62","author":"Whaley-Connell","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2018.10.095_bib0075","first-page":"43","article-title":"Angiotensin II receptor blockade and ventricular remodelling","volume":"6","author":"Anavekar","year":"2005","journal-title":"J. Renin. Syst."},{"key":"10.1016\/j.biopha.2018.10.095_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/cs1040109","article-title":"Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse","volume":"104","author":"Patten","year":"2003","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2018.10.095_bib0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/eurjhf\/hfp191","article-title":"Functional effects of glucose transporters in human ventricular myocardium","volume":"12","author":"Lewinski","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2018.10.095_bib0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.10631","article-title":"Human cardiomyocytes express high level of Na+\/glucose cotransporter 1 (SGLT1)","volume":"90","author":"Zhou","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.10.095_bib0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1463-1326.2011.01511.x","article-title":"The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia","volume":"14","author":"DeFronzo","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2018.10.095_bib0100","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.10.095_bib0105","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME\u00ae trial","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2018.10.095_bib0110","first-page":"92","article-title":"Jardiance (Empagliflozin), an SGLT2 inhibitor, receives FDA approval for the treatment of patients with type 2 diabetes","volume":"8","author":"Fala","year":"2015","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.biopha.2018.10.095_bib0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2011.01517.x","article-title":"Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors","volume":"14","author":"Grempler","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2018.10.095_bib0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/2229-516X.165363","article-title":"Sodium glucose co-transporter inhibitors - A new class of old drugs","volume":"5","author":"Malhotra","year":"2015","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.biopha.2018.10.095_bib0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1185\/03007990802710422","article-title":"From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus","volume":"25","author":"Bays","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.biopha.2018.10.095_bib0130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4158\/EP.14.6.782","article-title":"Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus","volume":"14","author":"Abdul-Ghani","year":"2008","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.biopha.2018.10.095_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1210\/jc.2009-0473","article-title":"Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus","volume":"95","author":"Nair","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2018.10.095_bib0140","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jpi.12357","article-title":"The cardioprotective effect of melatonin and exendin\u20104 treatment in a rat model of cardiorenal syndrome","volume":"61","author":"Chua","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2018.10.095_bib0145","first-page":"804","article-title":"Peripheral blood-derived endothelial progenitor cell therapy prevented deterioration of chronic kidney disease in rats","volume":"7","author":"Huang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2018.10.095_bib0150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/jpet.115.225375","article-title":"Early administration of carvedilol protected against doxorubicin-induced cardiomyopathy","volume":"355","author":"Chen","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.10.095_bib0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12967-014-0357-0","article-title":"Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats","volume":"12","author":"Chua","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2018.10.095_bib0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jpi.12326","article-title":"Melatonin pretreatment enhances the therapeutic effects of exogenous mitochondria against hepatic ischemia\u2013reperfusion injury in rats through suppression of mitochondrial permeability transition","volume":"61","author":"Chen","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2018.10.095_bib0165","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1046\/j.1523-1755.64.s87.5.x","article-title":"Chronic kidney disease and cardiovascular disease in the Medicare population: management of comorbidities in kidney disease in the 21st century: anemia and bone disease","volume":"64","author":"Collins","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.10.095_bib0170","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.10.095_bib0175","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/aje\/kwn033","article-title":"Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population","volume":"167","author":"Astor","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.biopha.2018.10.095_bib0180","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2018.10.095_bib0185","first-page":"878","article-title":"Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast\u2010induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"82","author":"And\u00f2","year":"2013","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.biopha.2018.10.095_bib0190","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000143547.55093.17","article-title":"The clinical challenge of cardiorenal syndrome","volume":"110","author":"Shlipak","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2018.10.095_bib0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MAJ.0b013e318258f482","article-title":"Estimated glomerular filtration rate as a useful predictor of mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"345","author":"Tsai","year":"2013","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.biopha.2018.10.095_bib0200","doi-asserted-by":"crossref","first-page":"54747","DOI":"10.18632\/oncotarget.18287","article-title":"Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome","volume":"8","author":"Sheu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.10.095_bib0205","doi-asserted-by":"crossref","first-page":"100002","DOI":"10.18632\/oncotarget.21727","article-title":"Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218344184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218344184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:33:32Z","timestamp":1777876412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218344184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":41,"alternative-id":["S0753332218344184"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.095","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}